| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |